Papers
1
Total Citations
4
H-Index
1
About
Dr. Hanbo Liu is a pioneering urologic surgeon whose research focuses on advancing nephron-sparing surgery through innovative vascular interventions. His most cited work, a 2023 study on superselective transarterial embolization (STE) for zero-ischaemia robotic-assisted laparoscopic partial nephrectomy (RALPN), represents a paradigm shift in renal tumor management. By demonstrating that preoperative STE can safely eliminate renal artery clamping during partial nephrectomy, Dr. Liu’s research directly addresses the critical challenge of preserving renal function while achieving complete tumor resection. His study of 32 T1 renal cancer patients showed that this combined approach maintains excellent oncologic outcomes while minimizing ischemic damage to healthy kidney tissue—a breakthrough that has already garnered 4 citations and growing clinical interest. Dr. Liu’s work bridges interventional radiology and robotic surgery, offering a reproducible technique that could reduce postoperative renal impairment for thousands of patients annually. His contributions are particularly impactful for complex renal tumors where traditional clamping risks permanent kidney damage. As a rising authority in minimally invasive urologic oncology, Dr. Liu continues to refine protocols that balance surgical precision with maximal organ preservation.
Research Focus
Key Achievements
Top Papers
- 1